AI AgentsNews
OpenAI acquires Orchestra Bio, adding its agent platform to Rosalind
OpenAI has acquired Orchestra Bio, a platform where people and AI agents coordinate drug development work, and is bringing its team and technology together with Rosalind. Terms weren't disclosed.
